AI Engines For more Details: Perplexity Kagi Labs You
Antihistamine Effects: Pheniramine maleate works by blocking the action of histamine, a substance produced by the body during an allergic reaction. By inhibiting histamine activity, pheniramine helps alleviate symptoms such as sneezing, itching, watery eyes, and runny nose.
Allergy Relief: Pheniramine maleate is commonly used to relieve symptoms of allergic rhinitis (hay fever), including nasal congestion, itching, and sneezing caused by exposure to allergens such as pollen, dust mites, or pet dander.
Cold and Flu Relief: Pheniramine maleate is often included in over-the-counter cold and flu medications to alleviate symptoms such as nasal congestion, runny nose, and sneezing associated with upper respiratory tract infections.
Sedative Effects: Pheniramine maleate has sedative properties and may cause drowsiness or sleepiness, especially at higher doses or when combined with other central nervous system depressants such as alcohol or certain medications. Patients should avoid activities requiring mental alertness, such as driving or operating machinery, until they know how pheniramine affects them.
Dry Mouth: Pheniramine may cause dry mouth as a side effect, which can be bothersome for some individuals. Maintaining adequate hydration and using sugar-free lozenges or gum may help alleviate this symptom.
Urinary Retention: Pheniramine can impair bladder function and lead to urinary retention, particularly in men with prostatic hypertrophy or individuals with pre-existing urinary issues. Patients should be monitored for urinary symptoms and advised to seek medical attention if they experience difficulty urinating.
Blurred Vision: Pheniramine may cause temporary blurred vision or difficulty focusing, particularly at higher doses. Patients should use caution when performing tasks that require visual acuity, such as driving or reading, until their vision returns to normal.
Gastrointestinal Effects: Gastrointestinal side effects such as nausea, vomiting, or stomach upset may occur with pheniramine use, although they are less common. Taking pheniramine with food may help minimize these effects.
Skin Reactions: In rare cases, pheniramine may cause allergic skin reactions such as rash, itching, or hives. Patients should discontinue use and seek medical attention if they develop any signs of a severe allergic reaction.
Drug Interactions: Pheniramine may interact with other medications, particularly other central nervous system depressants or drugs with anticholinergic properties, leading to additive effects on sedation or other side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Escherichia coli | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 1.6 | 1.6 | |
| Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.5 | |
| Allergic Rhinitis (Hay Fever) | 1.2 | 0.6 | 1 |
| Allergies | 1.8 | 0.9 | 1 |
| Allergy to milk products | 0.5 | 0.9 | -0.8 |
| Alzheimer's disease | 2.9 | 2.5 | 0.16 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.3 | 0.2 | 5.5 |
| Ankylosing spondylitis | 1.7 | 0.6 | 1.83 |
| Anorexia Nervosa | 0.3 | 1.8 | -5 |
| Antiphospholipid syndrome (APS) | 0.6 | 0.6 | |
| Asthma | 2.3 | 1.1 | 1.09 |
| Atherosclerosis | 1.5 | 0.6 | 1.5 |
| Atrial fibrillation | 1.2 | 1.2 | 0 |
| Autism | 3.1 | 3.3 | -0.06 |
| Autoimmune Disease | 0.9 | 0.5 | 0.8 |
| Barrett esophagus cancer | 0.3 | 0.3 | 0 |
| benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
| Biofilm | 1.2 | 1.2 | |
| Bipolar Disorder | 0.9 | 0.5 | 0.8 |
| Brain Trauma | 0.3 | 0.8 | -1.67 |
| Breast Cancer | 0.8 | 0.8 | |
| Cancer (General) | 0.3 | 0.3 | |
| Carcinoma | 2.1 | 0.3 | 6 |
| Celiac Disease | 1.6 | 0.3 | 4.33 |
| Cerebral Palsy | 0.6 | 0.8 | -0.33 |
| Chronic Fatigue Syndrome | 1.6 | 0.6 | 1.67 |
| Chronic Kidney Disease | 0.9 | 0.5 | 0.8 |
| Chronic Lyme | 0.8 | -0.8 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 1.1 | -0.22 |
| Chronic Urticaria (Hives) | 1.1 | 1 | 0.1 |
| Coagulation / Micro clot triggering bacteria | 1.1 | 0.8 | 0.38 |
| Cognitive Function | 0.6 | 0.8 | -0.33 |
| Colorectal Cancer | 3.9 | 1.3 | 2 |
| Constipation | 0.9 | 0.5 | 0.8 |
| Coronary artery disease | 1.1 | 1.5 | -0.36 |
| COVID-19 | 2.2 | 2.1 | 0.05 |
| Crohn's Disease | 3.5 | 1.8 | 0.94 |
| Cushing's Syndrome (hypercortisolism) | 0.3 | -0.3 | |
| cystic fibrosis | 0.8 | 0.8 | 0 |
| d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
| deep vein thrombosis | 2.1 | 1.1 | 0.91 |
| Denture Wearers Oral Shifts | 0.9 | 0.9 | |
| Depression | 3 | 1.8 | 0.67 |
| Dermatomyositis | 0.3 | 0.3 | |
| Eczema | 1.2 | 0.9 | 0.33 |
| Endometriosis | 1.4 | 0.8 | 0.75 |
| Eosinophilic Esophagitis | 0.3 | 0.3 | 0 |
| Epilepsy | 2.3 | 0.3 | 6.67 |
| erectile dysfunction | 1.2 | 1.2 | |
| Fibromyalgia | 0.5 | 0.6 | -0.2 |
| Functional constipation / chronic idiopathic constipation | 2.7 | 1.8 | 0.5 |
| gallstone disease (gsd) | 1.5 | 0.8 | 0.88 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.6 | 0.3 | 4.33 |
| Generalized anxiety disorder | 1.7 | 0.6 | 1.83 |
| Glioblastoma | 0.3 | -0.3 | |
| Gout | 0.6 | 0.6 | |
| Graves' disease | 0.3 | 1.1 | -2.67 |
| Gulf War Syndrome | 0.3 | 0.7 | -1.33 |
| Halitosis | 1.5 | 0.3 | 4 |
| Hashimoto's thyroiditis | 1.8 | 0.3 | 5 |
| Heart Failure | 2 | 0.5 | 3 |
| hemorrhagic stroke | 0.3 | 0.3 | |
| Hidradenitis Suppurativa | 0.9 | 0.9 | |
| High Histamine/low DAO | 0.8 | 0.8 | |
| hypercholesterolemia (High Cholesterol) | 0.2 | 0.2 | |
| hyperglycemia | 0.8 | 0.3 | 1.67 |
| hypertension (High Blood Pressure | 1.2 | 1.8 | -0.5 |
| Hypoxia | 1.1 | 1.1 | |
| IgA nephropathy (IgAN) | 0.9 | 1.4 | -0.56 |
| Inflammatory Bowel Disease | 3.5 | 2.7 | 0.3 |
| Insomnia | 0.6 | 1.1 | -0.83 |
| Intelligence | 0.5 | 0.3 | 0.67 |
| Intracranial aneurysms | 0.6 | 0.6 | |
| Irritable Bowel Syndrome | 3.2 | 1.7 | 0.88 |
| ischemic stroke | 0.8 | 1.4 | -0.75 |
| Liver Cirrhosis | 2.9 | 1.6 | 0.81 |
| Long COVID | 1.5 | 1.1 | 0.36 |
| Low bone mineral density | 0.5 | -0.5 | |
| Lung Cancer | 0.6 | 0.6 | |
| Lymphoma | 0.6 | 0.6 | |
| Mast Cell Issues / mastitis | 1.5 | 1.5 | |
| ME/CFS with IBS | 0.3 | 0.3 | 0 |
| ME/CFS without IBS | 0.3 | 0.3 | 0 |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.8 | 0.5 | 0.6 |
| Metabolic Syndrome | 2.9 | 2.1 | 0.38 |
| Mood Disorders | 2.8 | 1.7 | 0.65 |
| multiple chemical sensitivity [MCS] | 0.3 | 0.3 | |
| Multiple Sclerosis | 1.3 | 2.1 | -0.62 |
| Multiple system atrophy (MSA) | 0.1 | 0.1 | |
| myasthenia gravis | 0.9 | 0.5 | 0.8 |
| neuropathic pain | 0.8 | -0.8 | |
| Neuropathy (all types) | 0.3 | 1.1 | -2.67 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3 | 0.8 | 2.75 |
| NonCeliac Gluten Sensitivity | 0.3 | 0.3 | 0 |
| Obesity | 2.6 | 2.7 | -0.04 |
| obsessive-compulsive disorder | 2.6 | 0.9 | 1.89 |
| Osteoarthritis | 1.2 | 0.6 | 1 |
| Osteoporosis | 1.4 | 0.6 | 1.33 |
| pancreatic cancer | 0.9 | 0.3 | 2 |
| Parkinson's Disease | 2.6 | 3.1 | -0.19 |
| Polycystic ovary syndrome | 2.7 | 1.1 | 1.45 |
| primary biliary cholangitis | 0.3 | 0.6 | -1 |
| Primary sclerosing cholangitis | 1 | 1 | |
| Psoriasis | 1.2 | 1.2 | 0 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.7 | 1.8 | 0.5 |
| Rosacea | 0.5 | -0.5 | |
| Schizophrenia | 0.9 | 0.8 | 0.13 |
| scoliosis | 0.2 | 0.2 | |
| Sjögren syndrome | 1.2 | 0.3 | 3 |
| Sleep Apnea | 0.3 | 0.8 | -1.67 |
| Slow gastric motility / Gastroparesis | 0.5 | 0.5 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 1.1 | 1.1 | |
| Stress / posttraumatic stress disorder | 1.3 | 0.8 | 0.63 |
| Systemic Lupus Erythematosus | 2.1 | 0.5 | 3.2 |
| Tic Disorder | 0.3 | 0.3 | 0 |
| Tourette syndrome | 0.3 | 0.3 | 0 |
| Type 1 Diabetes | 2.4 | 1.2 | 1 |
| Type 2 Diabetes | 3.2 | 2.3 | 0.39 |
| Ulcerative colitis | 2.7 | 2.4 | 0.13 |
| Unhealthy Ageing | 2.2 | 0.5 | 3.4 |
| Vitiligo | 1.2 | 1.2 |
